Greenfern Medicinal Marijuana Ltd is a New Zealand company planning to undertake research to cultivate cannabis for human medicinal and research purposes. This research will spearhead the development of our CBD product range.
Our business is waiting on a proposed Amendment Bill to the Misuse of Drugs Act 1975 (currently in the 2nd sitting) to be finalised and for a licence to be awarded. Our application has already been submitted to the MoH and we are in touch with them regarding it.
More information about the Misuse of Drugs (Medicinal Cannabis) Amendment Bill can be read here.
Breeding and growing the highest quality Cannabis CBD strains.
Supercritical CO2 extraction producing concentrated oil for use in therapeutic products.
Located on-premise at a hydro power station. Our growrooms will be powered by clean green hydro power.
Diverse team with industry relevant and international growing experience.
Cutting edge distributed blockchain technology to track from seed to product.
Our team, advisors, partners and investors are a very diverse and unique group who all have a strong and aligned desire to bring medicinal marijuana to the mainstream in New Zealand.
Our business is currently awaiting an Amendment Bill to be passed and a permit from the Ministry of Health to be granted. Our intention is to raise capital that will be used to complete our facilities located at a hydro power station in order to prepare ourselves for the large waiting market of buyers here in New Zealand. The market for medicinal marijuana products in New Zealand is huge, and across the globe, that market is expected to be worth USD 55.8 billion by 2025. We are investigating our funding options and will update our community as soon as we decide how we will proceed. If you would like to speak to us directly about an investment please get in touch.
Projected US medical marijuana market: